2019
DOI: 10.1055/s-0039-1683409
|View full text |Cite
|
Sign up to set email alerts
|

Lysophosphatidylcholine is a Major Component of Platelet Microvesicles Promoting Platelet Activation and Reporting Atherosclerotic Plaque Instability

Abstract: Background Microvesicles (MVs) are small cell-derived vesicles, which are mainly released by activated cells. They are part of a communication network delivering biomolecules, for example, inflammatory molecules, via the blood circulation to remote cells in the body. Platelet-derived MVs are known to induce vascular inflammation. Research on the mediators and mechanisms of their inflammatory effects has attracted major interest. We hypothesize that specific lipids are the mediators of vascular inflammation cau… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
48
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 41 publications
(50 citation statements)
references
References 70 publications
2
48
0
Order By: Relevance
“…Given its effect on vascular smooth muscle cells (VSMCs), platelet‐derived LPA may substantially contribute to atheroprogression. Recently LPC has been suggested as a surrogate marker of plaque instability in atherosclerotic mice, and as a principal component of platelet‐derived microvesicles . LPC activates platelets through G2AR (Figure ).…”
Section: Platelets and Lipids: Age‐old Accomplicesmentioning
confidence: 99%
See 1 more Smart Citation
“…Given its effect on vascular smooth muscle cells (VSMCs), platelet‐derived LPA may substantially contribute to atheroprogression. Recently LPC has been suggested as a surrogate marker of plaque instability in atherosclerotic mice, and as a principal component of platelet‐derived microvesicles . LPC activates platelets through G2AR (Figure ).…”
Section: Platelets and Lipids: Age‐old Accomplicesmentioning
confidence: 99%
“…Leukotrienes (LTs) cause inflammation in asthma, while lipoxins terminate inflammation . LPC as a platelet chemoattractant promotes the formation of platelet–monocyte aggregates, the predominance of which is seen in peripheral circulation of ACS patients . Monocytes are a prime source of soluble tissue factor (TF) in blood, further substantiated by cardiovascular risk factors, eg, hypercholesterolemia; exaggerated by the presence of platelets; and reverted by statin administration .…”
Section: Platelets and Lipids: Age‐old Accomplicesmentioning
confidence: 99%
“…78 Furthermore, the comparison of the platelet lipid profiles from CAD patients with matched controls reveals that LPC is weakly detectable in platelets of healthy persons, but increased by several orders of magnitude in CAD patients and also found in vulnerable atherosclerotic plaques. 79,80 LPC has been reported to be concentrated in microvesicles from activated platelets which are important markers and factors in vascular inflammation and atherosclerosis. 81 Lipid profiling of platelet MV identified differences in the composition with higher amounts of PC and LPC compared with the activated parent platelets.…”
Section: Sphingolipidsmentioning
confidence: 99%
“…81 Lipid profiling of platelet MV identified differences in the composition with higher amounts of PC and LPC compared with the activated parent platelets. 80 Platelets express the lysophospholipid receptor G2A/GPR132 that is responsible for platelet activation through LPC. 80 LPA, a derivative of LPC, is implicated in platelet activation and atherosclerosis signaling through G-protein-coupled receptors of the LPAR (EDG) family.…”
Section: Sphingolipidsmentioning
confidence: 99%
See 1 more Smart Citation